CoChat

Neuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action

De Witte, Philippe, Littleton, John, Parot, Philippe, Koob, George · 2005 · CNS Drugs

The DOI matches its Crossref record, with a small difference in title or year; 125 of the 125 references it cites were found in a registry or an index.

Abstract

Acamprosate is an abstinence-promoting drug widely used in the treatment of alcohol dependence but which has a mechanism of action that has remained obscure for many years. Recently, evidence has emerged that this drug may interact with excitatory glutamatergic neurotransmission in general and as an antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5) in particular. These findings provide, for the first time, a satisfactory, unifying hypothesis that can bring together and explain the diverse neurochemical effects of acamprosate. Glutamic acid is involved in several aspects of alcohol dependence and withdrawal, many of which can be modified by acamprosate. For example, during chronic exposure to alcohol, the glutamatergic system becomes upregulated, leaving the brain exposed to excessive glutamatergic activity when alcohol is abruptly withdrawn. The surge in glutamic acid release that occurs following alcohol withdrawal can be attenuated by acamprosate. The elevated extracellular levels of glutamic acid observed in withdrawal, together with supersensitivity of NMDA receptors, may expose vulnerable neurons to excitotoxicity, possibly contributing to the neuronal loss sometimes observed in chronic alcohol dependence. In vitro studies suggest that the excitotoxicity produced by ethanol can effectively be blocked by acamprosate. Moreover, glutamatergic neurotransmission plays an important role in the acquisition of cue-elicited drinking behaviours, which again can…

Overview

Integrity signals

Registry

Crossref · 10.2165/00023210-200519060-00004

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 125 references

Research works printed but not linked: 22

  1. Pelc, 2002, Alcohol Clin Exp Res, 26, 1529, 10.1111/j.1530-0277.2002.tb02452.x · doi:10.1111/j.1530-0277.2002.tb02452.x
  2. Iorio, 1992, Mol Pharmacol, 41, 1142
  3. Harris, 1999, Alcohol Clin Exp Res, 23, 1563
  4. Leidenheimer, 1992, Adv Biochem Psychopharmacol, 47, 269
  5. Kumari, 2000, Prog Drug Res, 54, 152
  6. Masood, 1994, Mol Pharmacol, 45, 324
  7. Simson, 1991, J Pharmacol Exp Ther, 257, 225
  8. Dildy-Mayfield, 1992, J Pharmacol Exp Ther, 262, 487
  9. Smothers, 1997, J Pharmacol Exp Ther, 283, 1214
  10. Davidson, 1998, Alcohol Clin Exp Res, 22, 1205
  11. Mhatre, 1993, Alcohol Alcohol Suppl, 2, 331
  12. Devaud, 1995, Mol Pharmacol, 48, 861
  13. Zeise, 1990, Prog Clin Biol Res, 351, 237
  14. Berton, 1998, Alcohol Clin Exp Res, 22, 183, 10.1111/j.1530-0277.1998.tb03636.x · DOI
  15. Naassila, 1998, Alcohol Clin Exp Res, 22, 802, 10.1111/j.1530-0277.1998.tb03871.x · doi:10.1111/j.1530-0277.1998.tb03871.x · Paper page
  16. al Qatari, 1998, Alcohol Clin Exp Res, 22, 810, 10.1111/j.1530-0277.1998.tb03872.x · doi:10.1111/j.1530-0277.1998.tb03872.x · Paper page
  17. Booth, 1993, Alcohol Alcohol, 28, 593
  18. Dahchour, 2001, ddictologie, 23, 437
  19. Schmidt, 1994, J Neural Transm Suppl, 43, 63
  20. Prendergast, 2000, Alcohol Clin Exp Res, 24, 1855, 10.1111/j.1530-0277.2000.tb01990.x · doi:10.1111/j.1530-0277.2000.tb01990.x · Paper page
  21. Prendergast, 2000, Alcohol Clin Exp Res, 24, 1583, 10.1111/j.1530-0277.2000.tb04578.x · doi:10.1111/j.1530-0277.2000.tb04578.x · Paper page
  22. Paille, 1995, Alcohol Alcohol, 30, 239

Cited by

See all 201

Metadata

Authors
De Witte, P., Littleton, J., Parot, P., & Koob, G.
Affiliations
  • University of Kentucky (US)
  • Scripps Research Institute (US)
Venue
CNS Drugs
Published
2005
Volume
19
Issue
6
Pages
517-537
ISSN
1172-7047 (ISSN-L)
OpenAlex
W2005949458
Cited by
201
References
124
Citations by year
2026: 6 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 4 · 2020: 8 · 2019: 8 · 2018: 5 · 2017: 7 · 2016: 11 · 2015: 9 · 2014: 11 · 2013: 13 · 2012: 12
FWCI
1.52
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Drugs (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
Keywords
acamprosate, alcoholism, alcohol withdrawal, glutamatergic neurotransmission, metabotropic glutamate receptor 5, neuroprotection, excitotoxicity, neuronal loss
MeSH terms
Acamprosate, Ethanol, Alcoholism, Animals, Drug Interactions, Humans, Models, Biological, Taurine, Receptors, Glutamate, Neuroprotective Agents, Excitatory Amino Acids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action. https://app.cochat.ai/papers/10.2165/00023210-200519060-00004
The paper
De Witte, P., Littleton, J., Parot, P., & Koob, G. (2005). Neuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action. CNS Drugs. https://doi.org/10.2165/00023210-200519060-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.